This is a report from the American Medical Association and Manatt Health that examines the response to the opioid crisis in four different states. Within this document, state-level efforts in six key areas were analyzed to identify best practices and provide a road map for all states to follow to mount a comprehensive response to the opioid crisis. 

A national survey of treatment providers done every year which can help assess the nature and extent of the services provided and in forecasting treatment resource requirements as well as analyze general treatment services trends.

This editorial highlights the consequences of a lack of real time data on drug overdose deaths. The authors discuss how with access to reliable and timely data, healthcare policymakers can implement strategies that identify and target specific at risk populations. 

This is a presentation by several collaborating organizations that describes the community response to the opioid crisis addressing upstream, midstream, and downstream interventions, such as cautious opioid prescribing, medications for opioid use disorder, and overdose prevention, respectively. 

This is an academic paper that provides an overview of the neurobiology and neuroscience of opioid use disorder (OUD), with diagrams showing the parts of the brain affected and the science underlying the high risk of recurrence of OUD symptoms. 

This federally-funded resource center provides a comprehensive list of resources and research specific to telehealth in substance use disorder treatment. 

The Ohio Mental Health and Addiction Services Coronavirus Opioid Treatment Providers FAQ gives these organizations guidance on navigating state and federal regulations for methadone and buprenorphine during the Covid pandemic. 

This is an academic paper that examines polysubstance use disorders, the need for treatment systems to account for their high prevalence, and the high risks of developing more than one substance use disorder. For example, the increased risk of developing heroin dependence is twofold for alcohol misusers, threefold for cannabis users, 15-fold for cocaine users, and 40-fold for prescription misusers. Behavioral and neural circuitry in the context of co-use of substance is explored. 

This is a report from SAMHSA that highlights 10 collaborative faith-based partnerships and outlines the steps taken by these teams in establishing a foundation for sustained strategic partnerships among community and interfaith leaders to support prevention, treatment, and recovery needs in their communities.

This is an academic paper that provides an overview of the trajectory of the opioid crisis through the lens of a structural and social determinants of health framework. Having an understanding of the root causes of the opioid crisis, such as upstream structural factors, can inform comprehensive interventions to a complex public health emergency. 

This employer toolkit, developed by the Minnesota Department of Health and the Minnesota Business Partnership, uses a five-step approach to prevent and address opioid use disorder and other substance use disorders within the workplace. The toolkit can be customized to fit an employer's needs. 

This is a presentation by Dr. Sharon Levy of Boston Children’s Hospital that gives an overview of the impact of opioid misuse on adolescents, including an emphasis on youth brain development and the risk factors that lead to opioid misuse.